University College London's new wearable brain imaging device unveils how babies' brains react in natural settings, shedding ...
Inflammatix secures $57M for its breakthrough infectious disease test, pending FDA review, aiming to revolutionize sepsis ...
Travere Therapeutics has achieved a major milestone with the FDA granting full approval for Filspari, a groundbreaking treatment designed to slow kidney function decline in adults with primary IgA ...
Vita Animal Health has introduced an enhanced version of its cardiac health supplement, Omnicardio Plus, specifically designed for cats and dogs. This new formula features astaxanthin, a potent ...
NHS dental services on the Isle of Wight have reached a breaking point as yet another practice faces closure due to serious staff shortages. This is the sixth closure in the past 18 months, raising ...
Zepp Health Corporation, a leading innovator in smart wearables, has teamed up with wellness app Wild.AI to introduce advanced women’s health features to Amazfit smartwatches. Starting with the ...
For the first time in the UK, The Royal Marsden NHS Foundation Trust and Automata Technologies have partnered to launch a robotic genomic testing facility for cancer patients. This cutting-edge ...
Carestream Dental, a leading provider of digital dental solutions, has secured a substantial $525 million investment through a recapitalization led by General Atlantic Credit’s Atlantic Park fund.
In a significant breakthrough for the life sciences industry, Pfizer and Valneva have announced encouraging results for their Lyme disease vaccine candidates. The phase 2 trials demonstrated strong ...
UK-based healthtech startup Doccla has raised £35m, led by European VC Lakestar, with participation from new investor Elaia and existing backers General Catalyst, Speedinvest, and Bertelsmann. Founded ...
Eli Lilly has achieved significant strides in diabetes care with its weekly insulin injection, efsitora alfa. Recent Phase III trials reveal promising outcomes, posing as a likely competition to Novo ...